• Early MPH treatment induces persistent alterations in reproductive parameters.
Introduction
The attention deficit hyperactivity disorder (ADHD) is one of the most frequent neuropsychiatric disorders commonly diagnosed in children and adolescents. Its worldwide prevalence is of 5.29% [1] and is defined by persistent symptoms of inattention, hyperactivity and impulsivity [2] .
Although ADHD has been established as a disorder acquired during childhood [3] , longitudinal follow-up studies reported that ADHD symptoms diagnosed during infancy could persist into adulthood with a margin that exceeds 60% [4] [5] [6] .
For this psychiatric disease, methylphenidate (MPH) is the main psychostimulant drug prescribed to children and adolescents to treat ADHD [7] [8] [9] . It acts by blocking the dopamine (DA) and noradrenaline (NA) transporters [10, 11] , although it is suggested that the therapeutic effect of MPH is mainly due to the DA transporter blockade [12] .
Some studies have evidenced the DA role on the pre-pubertal maturation stages in different vertebrate species [13] [14] [15] . It is known that early exposure to MPH could lead to long-lasting alterations in brain DA pathways and natural reward systems [16, 17] , which are related to sexual behavior performance [18] . In this sense, impairment of sexual behavior performance was demonstrated in adult rats treated with MPH during adolescence [17] , and alterations on hormonal profile [19] and spermatogenesis [20, 21] were observed shortly after drug discontinuation.
Based on these considerations, this study was conducted in order to evaluate the enduring effects on reproductive function in adult male rats submitted to similar MPH treatment established for ADHD, from late infancy to early adulthood periods [22] .
Materials and methods

Animals and treatment
A total of 10 male and 20 female Wistar rats (85-90 days) from the colony of the State University of Londrina (UEL) were used as parental generation. They were kept in a controlled environment with temperature at 21 ± 2°C; 12 h light/dark cycle (lights on at 6:00 a.m.) and had free access to regular lab chow (Nuvital™, Paraná, Brazil) and tap water. Rats were mated (2 females and 1 male per cage) and gestational day 0 was determined if there were sperm and estrus phase cells in vaginal smears. On post-natal day (PND) 4, litters were culled to 8 pups keeping 4 males and 4 females wherever possible. Male pups were weaned on PND 21 and divided into three groups (26 males/group).
-Control group (CTR): received distilled water daily, by gavage, from PND 21 to PND 60; -MPH 2.5 mg group (MPH 2.5): received 2.5 mg/kg of MPH (Ritalin™, Novartis) daily, by gavage, from PND 21 to PND 60; -MPH 5.0 mg group (MPH 5.0): received 5.0 mg/kg of MPH (Ritalin™, Novartis) daily, by gavage, from PND 21 to PND 60.
To avoid the sibling effects, no littermates were used for the same group. Rats were daily treated at 4-6 p.m. The drug was dissolved in distilled water immediately prior to the treatment.
In children, the effective dose range is 0.3-1.0 mg/kg MPH [23] . Applying the BW 3/4 scaling [24] , the equivalent dose in rats would be 1.7-5.5 mg/kg. The highest dose used in this study (5.0 mg/kg) would be equivalent to a clinically relevant dose in humans and higher doses were not tested since it is already described in the literature that oral administration of 5.0 mg/kg does not compromise weight gain [7] . The oral gavage method was chosen in order to provide the same administration route used in humans. All animal procedures were approved by the UEL Ethics Committee for Animal Research (CEUA 16381.2012.45). The experimental protocol is diagramed in Fig. 1. 
Parameters analyzed during development (PND 21-60)
Body weight
The body weight was measured daily during the treatment period as well as toxicity signs (e.g. lacrimation, piloerection, unusual respiratory pattern and tremors) were observed.
Physical sexual development
The anogenital distance (AGD, distance from the anus to the genital tubercle) was obtained weekly (PND 21, 28, 35, 42 ) through a vernier caliper until occurrence of preputial separation. AGD was normalized through its division by the cube root of body weight. From PND 45 [25] , preputial separation was verified daily and considered as an indicator of the sexual maturity onset.
Parameters analyzed in adulthood (PND 100)
For the evaluation of male reproductive development, each group (CTR, MPH 2.5 and MPH 5.0) was divided into 2 subgroups (n = 11-15/subgroup): one group for testosterone level, sexual organ weight, sperm parameters and testis histomorphometric analysis and the other one for the sexual behavior evaluation.
Plasmatic testosterone quantification
Male rats were euthanized with diethyl ether and blood samples were collected from the abdominal aorta into syringes containing heparin, always at the same time. Immediately after collection, blood samples were centrifuged (2500 rpm for 20 min at 2°C) and the plasma was frozen until assayed. Blood plasma testosterone was measured by radioimmunoassay using ImmuChem™ Double Antibody 125 I RIA Kit (MP Biomedicals, Orangeburg, NY) according to the manufacturer's instructions. Samples were analyzed in a double assay format, the intra-assay coefficient of variation and the minimum sensitivity of the assay were 10.1% and 0.035 ng/ml respectively.
Collection of tissue and organs
The right testis and epididymis, vas deferens, ventral prostate and seminal vesicle (without the coagulating gland and full of secretion) were removed and their weights (absolute and relative to body weight) were determined. The right testis and epididymis were frozen at − 20°C for sperm counting. The left testis was collected for histomorphometric analysis.
Daily sperm production per testis, sperm number and transit time in the epididymis
Right testis was decapsulated and the caput/corpus and cauda segments from epididymis were separated. Homogenization-resistant testicular spermatids (stage 19 of spermiogenesis) and sperm in the caput/corpus epididymis and cauda epididymis were assessed as described previously by Robb et al. [26] , with adaptations of Fernandes et al. [27] . Mature spermatids were counted in a Neubauer chamber. To calculate daily sperm production (DSP), the number of spermatids at stage 19 was divided by 6.1, which is the number of days in one seminiferous cycle when these spermatids are present in the seminiferous epithelium. Sperm transit time through the epididymis was determined by dividing the number of sperm in each segment by the DSP.
Sperm motility, viability and morphology
Sperm motility analysis was performed according to Perobelli et al. [28] and Favareto et al. [29] . Sperm were obtained from the right vas deferens and diluted in 1 ml of modified HTF (Human Tubular Fluid, Irvine Scientific™) pre-warmed at 34°C. A 10 μl aliquot was placed in a Makler chamber (Irvine) and analyzed under a phase-contrast microscope (OSM-223287, Olympus) at 100 × magnification. One hundred sperms were evaluated per animal and were classified as motile or immotile [28] .
For sperm viability, the one step eosin-nigrosin staining technique was used [30] . 50 μl of spermatozoa in HTF was mixed with eosinnigrosin and directly examined, and 100 sperms per animal were evaluated and classified as viable or non-viable.
The evaluation of sperm morphology was performed according to Fernandes et al. [27] . Sperm were recovered from the left vas deferens by flushing with 1 ml of formol-saline (10%) and smears were prepared on histological slides that were left to dry for 90 min. It was analyzed 200 spermatozoa per animal in a phase-contrast microscope (400 × magnification) [31] . Morphological abnormalities were classified into two general categories: head morphology (without characteristic curvature or isolated form, i.e., no tail attached) and tail morphology (broken or isolated i.e., no head attached) [32] .
Morphometric analysis
The left testis was preserved in 4% glutaraldehyde 0.01 M pH 7.2 sodium phosphate buffer. The fragments were routinely processed for embedding in plastic resin glycolmethacrylate (Historesin Embedding kit, Leica™). Histological sections of 5 μm were stained in sodium borate/toluidine blue at 0.1% [33] and analyzed under a phasecontrast microscope (OSM-223287, Olympus).
2.3.5.1. Testis stereology. The diameter of the seminiferous tubules was measured at 100 × magnification using an ocular micrometer. Fifteen cross sections of tubule profiles that were either round or nearly round were chosen randomly and measured for each animal. The volume densities of testicular tissue components were determined by light microscopy using a 100-intersection grid placed in the ocular of the light microscope. A total of 10 (1000 points) randomly chosen fields were scored for each animal at 400× magnification. The volume of each component of the testis was determined as the product of the volume density and testis volume. For subsequent stereological calculations, the specific gravity of testis tissue was considered to be 1.0 [34] . To obtain a more precise measure of testis volume, the testis capsule was excluded from the testis weight. The total length (in meters) of seminiferous tubules (LST) was estimated by the tubule seminiferous volume (TSV) in the testis and the average area of tubules obtained from each animal (πR 2 ; R = tubular diameter / 2, according to the formula:
Cell numbers.
To estimate the number of the different types of cells that compose the seminiferous epithelium in stage VII, the germ cell nuclei (spermatogonia A; spermatocyte I in preleptotene/leptotene; spermatocyte in pachytene; round spermatids) and Sertoli cell nucleolus were counted in 5 round seminiferous tubule cross-sections, chosen at random for each animal. For this purpose, the diameters of 10 nuclei (from germinative cells) or nucleoli (from Sertoli cells) were measured per animal. These counts were corrected for section thickness and for nucleus or nucleolus diameter, based on the procedure described by Abercrombie [37] and modified by Amann & Almquist [38] .
Estimates on Sertoli cell number per testicle were performed based on the Sertoli cell nucleolus corrected number per seminiferous tubule transversal section in stage VII and the total length of seminiferous tubule per testicle, following the formula by Hochereau-de Reviers and Lincoln [39] . The Sertoli cell index (SCI) was obtained from the ratio between the number of round spermatids per cross section and the number of Sertoli cell nucleoli per cross section of seminiferous tubules.
The individual volume of the Leydig cells was obtained from nucleus volume and the proportion between nucleus and cytoplasm. The Leydig cell nucleus volume was obtained from the knowledge of the mean nuclear diameter. For this purpose, fifteen nuclei were measured at 1000× for each animal. Leydig cell nuclear volume (μm 3 ) was obtained by the formula 4/3πR3, were R = nuclear diameter / 2. To calculate the proportion between nucleus and cytoplasm a 100-point square lattice was placed over the sectioned material at 400 × magnification. One thousand points over Leydig cells were counted for each animal. The number of Leydig cell per testis was estimated from the Leydig cell individual volume and the volume occupied by Leydig cell in the testis parenchyma [40] .
Sexual behavior evaluation
All behavioral assessments were performed in adult rats (beginning on PND 100) during the dark phase of a reversed light/dark cycle, under dim red light. The animals were allowed a 15-day period of adaptation to the reversed light/dark cycle before the beginning of the evaluations. The observations always started 4 h after the onset of darkness and were recorded by a video camera, linked to a monitor in an adjacent room.
2.3.6.1. Copulatory behavior. For the copulatory behavior evaluation, each male was placed into a Plexiglass cage with 20 × 40 × 50 cm (height × width × length) and, after 5 min, a female in natural estrous was introduced into the cage. As described previously [41] , during 30 min, the following parameters were recorded: intromission (vaginal penetration, this behavior starts with a mount, but suddenly the male makes a deep thrust forward and stops pelvic thrusting, then vigorously withdraws and always licks his genitals), and ejaculation (starts with an intromission, but after vaginal penetration the male remains on the female for 1-3 s) latencies; and the total number of intromissions and ejaculations. If a male did not mount within 10 min, the evaluation was interrupted and repeated another day with another female. If the male failed again in the second evaluation, it was considered sexually inactive [42] .
2.3.6.2. Sexual incentive motivation. The same animals evaluated for copulatory behavior were submitted to the sexual incentive motivation (SIM) test. In this test, a rectangular arena with 50 × 50 × 100 cm (height × width × length) that presents two openings that communicate with two small arenas with 25 cm 2 was used . The small arenas were diagonally opposed to each other and the communication with the main arena is closed with wire mesh. For the test, an estrous female (sexual incentive) was placed in one of the small arenas and a sexually active male (social incentive) was placed in the other one. The floor of the main arena had two 25 cm 2 divisions (zones) in front of each small arena opening, named sexual incentive and social incentive zones, respectively. The experimental male was placed in the center of the main arena and observed for 20 min. The number of visits and the total time spent visiting each zone were quantified, and a preference score was calculated as (time spent in female zone / total time spent in both incentive zones) × 100 [43] .
Statistical analysis
Initially, an exploratory analysis was conducted to evaluate normal distribution (Shapiro-Wilk test) and homogeneity of variance (Levene's test) of each variable. Variables that presented normal distribution and homogeneity of variance were analyzed by ANOVA complemented with Bonferroni post-hoc test. Conversely, for other variables Kruskal-Wallis complemented with Dunn's test was performed. For body weight and AGD (PND 21, 28, 35 and 42), repeated measures ANOVA (RMANOVA) was applied with day as the within-subject factor and treatment as the between-subject factors. Differences were considered significant if p b 0.05.
Results
Development (PND 21-60)
Body weight and physical development
Body weight is given in Fig. 2 
Adulthood (PND 100)
Body weight and reproductive organ weight
The body weight and reproductive organ weight of adult male are given in Table 1 . No significant differences as a result of the MPH treatment were found in body weight [F (2, 43) = 0.68, p = 0.51]. Mean weights (absolute and relative to body weight) of testes, epididymis, vas deferens, seminal vesicle and prostate were similar among experimental groups.
Plasma testosterone quantification
The repeated administration of MPH did not cause significant alteration in the plasma testosterone level in adulthood (CTR group: 2.78 ± 0.86, n = 10; MPH 2.5 group: 2.57 ± 0.57, n = 11; and MPH 5.0 group: 2.31 ± 0.43, n = 12, ng/ml) [F (2, 32) = 0.15, p = 0.86].
Sperm analysis
Data from sperm parameters are shown in Table 2 . There was no effect of MPH treatment on sperm count, motility and viability in either dose. However, the results given by sperm morphology revealed a significant increase in abnormal tail morphology in MPH 2.5 group [F (2,43) = 4.90, p = 0.01] when compared to CTR group.
Histomorphometric evaluation
As seen in Table 3 , both MPH doses promoted a significant [F (2,38) = 8.71, p = 0.001] increase in the interstitial tissue volume compared to CTR group (ANOVA complemented with Bonferroni). Fig. 3 demonstrates the seminiferous tubules and the interstitial tissue differences among groups.
In Table 4 Values for the germ cell population are shown in Table 5 . Bonferroni post hoc analyses revealed a significant increase of type A spermatogonia in MPH 5.0 group [F (2, 38) 
Sexual behavior evaluation
The sexual behavior evaluation results are shown in Table 6 . The repeated MPH treatment did not influence either copulatory behavior or sexual motivation parameters (CTR group: n = 11; MPH 2.5 group: n = 11; MPH 5.0 group: n = 12, p N 0.05) in adult rats.
Discussion
The growth pattern of an animal during treatment is a reliable indicator in the investigation of toxic effects [44] . In humans, the loss of weight is the most common adverse effect associated with MPH treatment and usually disappears with time [45, 46] . In rats, studies have shown that oral MPH treatment decreases body weight in a dose-dependent manner, as observed in neonatal rats at doses above 50 mg/kg/day [7] , as well as in adult rats in daily doses above 20 mg/kg [47] . In the present study, the MPH administrations did not induce body weight reduction during the treatment period. It is already described in the literature that daily doses of 5 mg/kg (via gavage) do not induce body weight loss during development [7] . In that way, in order to rule out the possibility of reproductive disturbances incurred by weight loss, since the decrease in this parameter is related to changes in sexual maturation [48, 49] , MPH doses that have no influence in body weight were selected.
In the current study, male rats were treated with MPH during the puberty period, period in which major rearrangement in architecture and brain plasticity occurs, defining neuroendocrine and behavioral changes that can persist throughout life [50] . Puberty initiates by the resurgence of a pulsatile profile of hypothalamic GnRH release, activating pituitary-gonadal axis in the late juvenile stage of development [51, 52] . The hypothalamus receives afferent inputs from many neuronal systems for GnRH release [53] . In turn, dopaminergic inputs from anteroventral periventricular nucleus (AVPV) neurons were recently described as one of the most potent inhibitors of GnRH neuron excitability [54] . Despite the potential interference on reproductive system, the repeated treatment with MPH did not affect the onset of puberty, observed by the day of preputial separation, in this study. There are few data in literature about the effects of MPH on the pubertal development. In juvenile rhesus monkey, delayed occurrence of the testicular descent (in crescent doses from 3 mg/kg to 25 mg/kg/day) [55] , which is a reliable marker of the initiation of puberty in these animals [56] was shown. Although the divergence among the results may be explained by inter-species differences, the absence of studies in Table 4 Biometric parameters of testicular parenchyma of male rats at PND 100.
CTR [14] MPH 2. literature restrains the discussion. In addition, the present study is the first to investigate the relationship of MPH and pubertal development in male rats. Evidences reinforce the concept that MPH might promote changes in sexual hormone profile due to interference on pulsatile release of hypothalamic GnRH [57] , or a possible direct impairment of the Leydig cell function [19] , which may affect the weight of hormone-dependent organs and hormonal profile. Since MPH is commonly prescribed for children and adolescents with ADHD and the treatment can be extended until early adulthood, the present study aimed to evaluate the MPH effects near 40 days after the end of treatment. In this study, the MPH treatment did not alter the reproductive organ weight as well as testosterone levels in adulthood. Organ weight changes are often associated with treatment-related toxic effects of a drug [58] . It has been demonstrated that 90 days of treatment at the oral doses of 10 mg/kg but not 5 mg/kg decreased testicular weight in rats [20] , corroborating with our results. In addition, MPH treatment with a substantially higher dose (100 mg/kg) also led to a reduction in weight of the prostate being no longer observed after 30 days of the end of treatment [47] . In this sense, it is suggested that, probably, the doses used in this study, did not cause changes in hormone-dependent organ weights and if changes occurred, they were not persistent. In regard to testosterone level, a decrease in plasma concentration of this hormone was observed shortly after 11 week of treatment with MPH (10 mg/kg, gavage) in adult rats [21] . However, as seen in Adriani et al. [19] , this reduction also appeared to be transient, since there was normalization of the testicular testosterone concentration two months after treatment discontinuation (2 mg/kg, i.p.).
Our findings showed that repeated treatment with MPH altered sperm morphology observed by an increase in tail abnormality in MPH 2.5 group in relation to control group but not in MPH 5.0 group. Nonmonotonic (biphasic) dose-response curve is linked to numerous chemicals where an increase in the response is observed at the lowest dose followed by a decrease at the highest dose, or vice versa [59] . Biphasic dose-response relationships of DA and/or its agonists are reviewed by Calabrese [60] in a wide range of endpoints in rats (i.e., locomotion, pain sensitivity, diastolic blood pressure, artery tension, prolactin secretion, oxytocin release, heart rate, memory, and neuronal adenylate cyclase activity). However, no evidence for this same pattern to MPH has been described until now. Although the exact mechanism of DA and NA signaling is not yet identified, the relevant presence of DA and NA receptors in testicular tissue and in all germ cells (pre-and post-meiotic phase) [61, 62] suggests that MPH treatment could have a direct action in these locals.
In the testes, there was an increase in interstitial tissue volume in both MPH treated groups. Testis consists mainly of the seminiferous tubules, where the spermatogenesis process occurs [63] , and of the interstitial space between the tubules, which has an endocrine function [64] . The interstitial compartment consists of Leydig cells, mesenchymal cells, myoid cells, endothelial cells, pericytes, and macrophages [65] . With the exception of the Leydig cells, the differential count of all interstitial cells was not performed in our study, thereby, it was not possible to identify whether quantitative changes in other cell types would be present here. However, the MPH treatment resulted in different changes in cell population of the germinal epithelium observed by the increase in the number of type A spermatogonia in MPH 5.0 group while in MPH 2.5 group there was a reduction in the number of spermatocyte I in the preleptotene/leptotene phase. Spermatogenesis comprises a highly organized process that produces male haploid germ cells originated from diploid spermatogonial stem cells [66] and takes around 48-53 days in rats [67] . It is possible that MPH treatment has impaired gametogenesis and changes were still present even after 40 days recovery period, probably by affecting germ cells [68] . Also, it is known that the progression of type A spermatogonia until the stage of pachytene spermatocyte phase is a FSH dependent process [69] playing an important regulatory role on the proliferation and renewal of spermatogonia type A at the initial stages of spermatogenesis [70, 71] . Although in the present study the FSH was not measured, the results could also suggest an action of MPH on the release of GnRH, and consequently, altering FSH, since dopaminergic pathways work in the modulation of GnRH release [53] . Despite changes in spermatogenesis which has been demonstrated in several studies [19] [20] [21] , to date, there is no basis in the literature that reinforces this hypothesis, correlating MPH on the release of gonadotropins in male rats.
Regarding sexual behavior, there is evidence supporting the role of medial preoptic area projections interacting with the mesolimbic DA system to promote the appetitive and consummatory aspects of sexual behavior [72] . Indeed, the neurobehavioral functioning in adult life could be influenced by environmental, emotional and drug experiences during development [73] [74] [75] [76] . Despite the MPH capacity to change DA levels during development of the organism and that this neurotransmitter is involved in the establishment of reproductive behavior, no influences in sexual behavior were observed in this study. Impairment in sexual behavior was seen in rats after treatment with 4 mg/kg/day (i.p.) [17] , even six weeks after the last MPH injection. It is known that intraperitoneal administration of MPH, when compared to the same oral dose has greater central bioavailability to induce locomotor response [77] . It is suggested that the divergent results found between our study and from Bolaños' group [17] might be related to the bioavailability inherent to the administration route used.
The present study shows that repeated treatment with MPH during late infancy until early adulthood may impact the reproductive function of adult male rats. Data from the literature reinforce the possibility of a direct action of MPH on spermatogenesis. These results underscore the need for further research aimed at understanding the mechanisms involved.
Conclusions
To summarize, the present study revealed that repeated MPH administration during periods corresponding childhood to early adulthood may have an impact in the testis. This was observed by changes in the volume of the interstitial tissue of the testicular parenchyma, and in morphometric parameters, such testicle volumetric composition and the cell population of germ cells of adult animals. The results could be attributed to changes in the hypothalamic-pituitary-gonadal axis or by direct action of MPH in male gonad.
These results reinforce the relevance of further investigation into the mechanisms by which MPH may act on male germ cells.
